Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Healthcare's"


6 mentions found


He shared 10 stocks to invest in for long-term gains and protection against a recession. If his macroeconomic predictions come true, the equity market will continue allowing him to play to his strengths in the near future. He also attributed his fund's success to the performance of the auto manufacturer Tenneco, the pharmaceutical distributor McKesson, and three energy stocks — EQT, Occidental Petroleum, and Schlumberger. To hedge against a recession, Muhlenkamp is also bullish on healthcare stocks. "Broadcom, in my opinion, is doing in tech what Warren Buffett does in industrials and energy — accumulating cash cows," he said.
Americans pay up to three times more for prescription drugs than people in other countries. In the US, people pay up to three times more for prescription drugs than people in other countries, and one in four Americans who take prescription drugs have trouble affording their medications. Because of the high cost of the drug, many diabetes patients cannot afford to pay for the treatment they need. Fast Facts: In the US, people pay 3X more for prescription drugs than people in other countries. The company is eliminating out-of-pocket costs for insulin and four other commonly used prescription drugs: epinephrine, glucagon, naloxone, and albuterol.
The justices rebuffed Glenhaven Healthcare's appeal of a lower court's ruling allowing the family of deceased resident Ricardo Saldana to proceed with the lawsuit in a California state court. Under then-President Donald Trump in January 2021, the U.S. Department of Health and Human Services, prodded by nursing homes, declared that cases filed in state court involving interpretation of the PREP Act should be moved to federal court. Circuit Court of Appeals ruled in the Saldana case that some state law claims can remain in state court. Glenhaven has argued that personal injury lawsuits against entities that provide COVID-19 countermeasures belong in federal court. The U.S. Chamber of Commerce, the American Hospital Association and the American Health Care Association, a nursing home industry group, weighed in to support its petition to the Supreme Court.
Maven, the women and family health startup, has raised $90 million in a new fundraising round, and in a tough environment for venture funding. Maven reached unicorn status last August in a $110 million round right before the bottom dropped out of the tech sector. Maven has benefitted from greater focus on women's health, particularly since the Supreme Court overturned Roe V. Wade. Global family benefits growth and Medicaid are two areas that Maven is prioritizing with the new funding. The family benefits will build off of the virtual platform that grew during Covid and include new features for Maven Wallet, the company's financial reimbursement platform.
These 13 healthcare founders have raised venture capital for the first time as a recession looms. Their startups have landed anywhere from $5 million to $70 million in early-stage funding this year. "Serial entrepreneurs build consistent companies, but they usually don't build them to the same scale as first-time founders," he said. These 13 founders are taking on healthcare's rocky waters for the first time in 2022. Check out the full list, ordered from least to most money raised this year.
read moreSome of the largest U.S. hospitals said on Tuesday they are facing critical shortages of iodinated contrast media products. The Greater New York Hospital Association (GNYHA) warned on May 4 of temporary supply shortages of GE Healthcare's iodinated contrast media - specifically its Omnipaque products made in Shanghai. "We are working around the clock to expand capacity of our iodinated contrast media products," a GE spokesperson said after the company had to close its Shanghai facility for several weeks due to local COVID policies. GE Healthcare has four contrast media manufacturing facilities, including the one in Shanghai. A spokesperson for Bayer (BAYGn.DE), which competes with GE Healthcare in contrast media, said it is not facing a similar situation.
Total: 6